ESR2 and neoplasm: Interestingly, a study demonstrated that estrogen receptor beta (ERβ) silencing in MDA-MB-231 breast cancer cells induces the expression of syndecan-4 [65], suggesting endocrine regulation of syndecan-4 in this tumor entity.